4lh5

(Difference between revisions)

Revision as of 10:17, 25 December 2013

4lh5 is a 1 chain structure. Full crystallographic information is available from OCA.

Le Rouzic E, Bonnard D, Chasset S, Bruneau JM, Chevreuil F, Le Strat F, Nguyen J, Beauvoir R, Amadori C, Brias J, Vomscheid S, Eiler S, Levy N, Delelis O, Deprez E, Saib A, Zamborlini A, Emiliani S, Ruff M, Ledoussal B, Moreau F, Benarous R. Dual inhibition of HIV-1 replication by integrase-LEDGF allosteric inhibitors is predominant at the post-integration stage. Retrovirology. 2013 Nov 21;10(1):144. doi: 10.1186/1742-4690-10-144. PMID:24261564 doi:http://dx.doi.org/10.1186/1742-4690-10-144

@@ Line 1: / Line 1: @@
-'''Unreleased structure'''
+{{STRUCTURE_4lh5|  PDB=4lh5  |  SCENE=  }}
+===Dual inhibition of HIV-1 replication by Integrase-LEDGF allosteric inhibitors is predominant at post-integration stage during virus production rather than at integration===
+{{ABSTRACT_PUBMED_24261564}}
-The entry 4lh5 is ON HOLD  until Paper Publication
+==About this Structure==
+[[4lh5]] is a 1 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4LH5 OCA].
-Authors: Ruff, M., Levy, N., Eiler, S.
+==Reference==
+<ref group="xtra">PMID:024261564</ref><references group="xtra"/><references/>
-Description: Dual inhibition of HIV-1 replication by Integrase-LEDGF allosteric inhibitors is predominant at post-integration stage during virus production rather than at integration
+[[Category: Eiler, S.]]
+[[Category: Levy, N.]]
+[[Category: Ruff, M.]]
+[[Category: Transferase-transferase inhibitor complex]]